Form 4: Outset Medical General Counsel Sells Shares to Cover Tax Obligations

Sentiment:

SEC Form 4 Filing


Outset Medical's General Counsel, John L. Brottem, sold 3,203 shares of common stock to cover tax obligations related to vesting of restricted stock units.

Summary

  • John L. Brottem, General Counsel of Outset Medical, Inc., sold 3,203 shares of common stock on November 15, 2024.
  • The sale was executed at a price of $0.8 per share.
  • This transaction was a 'sell to cover' to satisfy tax withholding obligations related to the vesting of 5,888 shares of common stock underlying RSUs.
  • The RSUs were granted on March 15, 2021, January 26, 2022, and January 6, 2023.
  • Following the transaction, Mr. Brottem beneficially owns 227,092 shares of Outset Medical common stock.

Sentiment

Score: 5

Explanation: The document describes a routine transaction for tax purposes, not a significant event that would impact the company's outlook. The sentiment is neutral.

Management Comments

  • The sale was made to satisfy tax withholding obligations through a 'sell to cover' transaction and does not represent a discretionary trade by the reporting person.

Industry Context

This is a routine transaction for company executives who receive stock-based compensation. It is common for executives to sell shares to cover tax obligations when restricted stock units vest.

Comparison to Industry Standards

  • The 'sell to cover' transaction is a standard practice across publicly traded companies.
  • Many companies use RSUs as part of their compensation packages, and executives often sell a portion of the shares upon vesting to cover taxes.
  • The sale of 3,203 shares is not unusual for an executive at this level.

Stakeholder Impact

  • The transaction has a minimal impact on shareholders as it is a routine sale to cover tax obligations.
  • The sale does not indicate any change in the executive's confidence in the company.

Key Dates

DateDescription
03/15/2021Date of one of the RSU grants that triggered the tax obligation.
01/26/2022Date of one of the RSU grants that triggered the tax obligation.
01/06/2023Date of one of the RSU grants that triggered the tax obligation.
11/15/2024Date of the stock sale transaction.
11/18/2024Date of the signature on the Form 4 filing.

Keywords

Outset Medical, John L. Brottem, stock sale, tax obligations, restricted stock units, RSUs, insider trading, Form 4

Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.